A 27-year-old woman with a history of nephrolithiasis presented for a renal ultrasound prior to lithotripsy. A cystic structure in the upper pole of the right kidney contained highly echogenic material.
A 27-year-old woman with history of nephrolithiasis presented for a renal ultrasound prior to lithotripsy.
FINDINGS
Sagittal and transverse supine views (Figure 1A and 1B) of the right kidney demonstrate a cystic structure in the upper pole. This structure contained highly echogenic material that layered dependently and presented a sharp horizontal interface with the anechoic fluid content of the cyst. The echogenic material caused posterior shadowing. The rest of the kidney and the visualized liver appeared normal. Another transverse set of images of the same kidney showed layering and shifting of hyperechoic material in a cystic structure in the supine (Figure 2A), left lateral decubitus (Figure 2B), and right-side (Figure 2C) positions.
Milk of calcium layering in a calyceal diverticulum, milk of calcium layering in a renal cyst, renal calculus.
Milk of calcium layering in a calyceal diverticulum.
Milk of calcium in a calyceal diverticulum or renal cyst can pose a diagnostic dilemma. Milk of calcium is a fine colloidal suspension of precipitated calcium salts (carbonate, phosphate, and oxalate) and may be radiopaque or radiolucent. If radiopaque, it may closely mimic renal calculus. It is important to distinguish milk of calcium from other entities, specifically renal calculus, to avoid unnecessary intervention. Milk of calcium is usually asymptomatic and of little clinical significance. In this case, lithotripsy was canceled.
Although no definitive factors or pathogenetic mechanisms are known, milk of calcium is known to occur in urinary tract locations where there is suboptimal drainage from a cavity such as a calyceal diverticulum. Factors thought to contribute to the development of milk of calcium include stasis, urinary tract infection, and long-term physical immobility as a result, for example, of spinal cord injury or chronic debilitating illness.
Gravity-dependent sonography is a sensitive and specific method of diagnosis. According to a 1992 study by Yeh et al, the main ultrasound features include highly echogenic material layering in the dependent part of a cystic-appearing mass, a sharp horizontal-level, mobile material that changes positions as patient moves, echogenic substance associated with reverberation (not seen in this case), and usually no shadowing unless milk of calcium is present in larger amounts. CT scan and plain radiographs in supine and standing positions (the latter not always feasible) can also show the layering of hyperdense calcium salts, thereby leading to the diagnosis.
Case submitted by Oksana H. Baltarowich, M.D., an associate professor of radiology at Thomas Jefferson University, and Chaitali Shah, M.D., a radiology resident at New York Presbyterian Hospital of Columbia University. This case provided courtesy of Sono-World (www.sono-world.com).
García-Cuerpo E, Martinez F, Llorente C, et al. New location of milk-of-calcium. Urology 1985;25(4):425-427.
Melekos MD, et al. Milk of calcium cysts masquerading as re-nal calculi. Eur J Radiol 1998;28(1):62-66.
Patriquin H, Lafortune M, Filia-trault D. Urinary milk of calcium in children and adults: use of gravity-dependent sonography. AJR 1985;144(2):407-413.
Shekarriz B, Lu HF, Stoller ML. Correlation of unilateral urolithiasis with sleep posture. J Urol 2001;165(4):1085-1087.
Vaidyanathan S, Parry R, Parsons KF, et al. Milk of calcium in the inferior calyx of a hydronephrotic kidney in a tetraplegic patient-a diagnosis to be made before scheduling for extracorporeal shock wave lithotripsy. Spinal Cord 2000;38(11):325-326.
Yeh HC, Mitty HA, Halton K, et al. Milk of calcium in renal cysts: new sonographic features. J Ultra-sound Med 1992;11(5):195-203.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.